“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+4
Medis specializes in out-licensing high-quality generic pharmaceuticals to third-party pharmaceutical companies. Established in 1985, we offer a broad portfolio of 185 generic pharmaceutical products, mainly in the form of tablets, capsules and injections. Our portfolio includes a growing range of specialist oncology products and product formulations, predominantly solid oral dosages. We develop these products in house and provide our customers with the necessary regulatory support. In fact, we have a proven track record in securing regulatory approval prior to patent expiries, and have supported our customers in obtaining marketing authorizations in over 140 countries. Medis has full backing from our...
Generic pharmaceuticals,registration dossiers,intellectual property,oncology products,specialty pharmaceuticals,over-the-counter (otc),generic rx,business development,and out-licensing
Medis operates in the Pharmaceutical manufacturing industry.
Medis's revenue is $5.50m
Medis has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.